Case todayBrokenLate SEC filing · Nov 18, 2026The case · mixed · Oct 19, 2026Own AAME if AAME is a small specialty insurer whose equity value depends less on premium growth than on whether disciplined underwriting and capital preservation can turn a stable niche book back into durable profits.4 conditions2 strengthening · 1 holding · 1 weakeningNext resultsNot scheduledNo date filed yet

AAME at a glance

The past year

Chart

−55.1% $1.31, close Nov 17

From the highest close
−59.3%
Vs the 200-day average
−30.5%
Nov 14, 2025Daily close, Atlantic AmericanNov 17, 2026

Short interest

History

62,902 shares

Of shares outstanding
0.31%
Since the last report
+148.5%
Days to cover
1.0 day
Settled
Oct 30, 2026

Insider buying, 7 days

Filings

None filed this week

Form 4s filed
Nov 12 – Nov 18

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

AAME price history

Latest price$1.30Today+$0.12 (+10.17%)
AAME -5.10%S&P 500 -4.78%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • AAME’s specialty-market positioning keeps policy demand from collapsing, giving management time to fix underwriting rather than shrinking the book in a disorderly way.StrengtheningMateriality: High

    Annual GAAP revenue was $188.227 million in FY2024 versus $186.793 million in FY2023, indicating near-term stability rather than a runoff-like decline. If the niche book stays intact, earnings can recover through pricing and claims control; if the book shrinks, fixed costs and capital strain become harder to absorb.

    Watch: Independent agents, brokers, or program partners move niche accounts to larger insurers with better ratings, broader products, or lower prices.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual GAAP revenue was $188.227 million in FY2024 versus $186.793 million in FY2023, indicating near-term stability rather than a runoff-like.

    Open source ↗
  • The core turnaround requires AAME to reprice and underwrite faster than claims severity and reserve needs rise; otherwise stable niche revenue remains economically unattractive.WeakeningMateriality: High

    This is the difference between a viable going-concern insurer and a company that writes business but destroys equity value. This is the difference between a viable going-concern insurer and a company that writes business but destroys equity value.

    Watch: Medical-cost inflation or adverse morbidity in life and health products outpaces approved rate increases.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The core turnaround requires AAME to reprice and underwrite faster than claims severity and reserve needs rise; otherwise stable niche.

    Open source ↗
  • AAME’s liquidity and positive operating cash generation give the company runway to repair underwriting without immediate balance-sheet distress.StrengtheningMateriality: Medium

    Cash and cash equivalents were $35.570 million at FY2024 year-end, up from $28.301 million at FY2023 year-end. If liquidity holds, management can reprice and manage claims over time; if liquidity breaks, shareholders face forced capital actions or value-destructive runoff.

    Watch: Reserve strengthening or claim payments require asset sales at unfavorable prices.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash and cash equivalents were $35.570 million at FY2024 year-end, up from $28.301 million at FY2023 year-end.

    Open source ↗
  • Per-share value depends on preserving equity capital, because AAME’s insurance liabilities make shareholder equity the shock absorber for underwriting mistakes, reserve changes, and investment marks.HoldingMateriality: Medium

    FY2024 GAAP stockholders’ equity remained positive at $99.613 million against FY2024 GAAP assets of $393.428 million. If equity stabilizes, the stock can be valued on normalized earnings and book support; if equity keeps eroding, any revenue recovery may accrue mainly to policyholders and creditors, not shareholders.

    Watch: Further adverse reserve development reduces statutory or GAAP capital.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY2024 GAAP stockholders’ equity remained positive at $99.613 million against FY2024 GAAP assets of $393.428 million.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

AAME’s specialty-market positioning keeps policy demand from collapsing, giving management time to fix underwriting rather than shrinking the book in a disorderly way. If the niche book stays intact, earnings can recover through pricing and claims control; if the book shrinks, fixed costs and capital strain become harder to absorb.

The core turnaround requires AAME to reprice and underwrite faster than claims severity and reserve needs rise; otherwise stable niche revenue remains economically unattractive. This is the difference between a viable going-concern insurer and a company that writes business but destroys equity value.

AAME’s liquidity and positive operating cash generation give the company runway to repair underwriting without immediate balance-sheet distress. If liquidity holds, management can reprice and manage claims over time; if liquidity breaks, shareholders face forced capital actions or value-destructive runoff.

Per-share value depends on preserving equity capital, because AAME’s insurance liabilities make shareholder equity the shock absorber for underwriting mistakes, reserve changes, and investment marks. If equity stabilizes, the stock can be valued on normalized earnings and book support; if equity keeps eroding, any revenue recovery may accrue mainly to policyholders and creditors, not shareholders.

All standing thesis claims
Original report summary

AAME is a small specialty insurer whose equity value depends less on premium growth than on whether disciplined underwriting and capital preservation can turn a stable niche book back into durable profits.

Evidence assessed Oct 19, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Atlantic American

Where the evidence on Atlantic American disagrees: Mixed on the latest evidence (Oct 19, 2026). Of its 4 thesis points, 2 strengthening, 1 holding and 1 weakening.

Bull case: what the evidence supports

  • AAME’s specialty-market positioning keeps policy demand from collapsing, giving management time to fix underwriting rather than shrinking the book in a disorderly way.

    sec.gov ↗

  • AAME’s liquidity and positive operating cash generation give the company runway to repair underwriting without immediate balance-sheet distress.

    sec.gov ↗

  • Per-share value depends on preserving equity capital, because AAME’s insurance liabilities make shareholder equity the shock absorber for underwriting mistakes, reserve changes, and investment marks.

    sec.gov ↗

Bear case: what the evidence questions

  • The core turnaround requires AAME to reprice and underwrite faster than claims severity and reserve needs rise; otherwise stable niche revenue remains economically unattractive.

    sec.gov ↗

Thesis-Break Engine

What has broken in Atlantic American’s thesis

Each break OptimistFi flagged on Atlantic American, dated — with what has historically followed the same kind of break across the market, not a forecast for Atlantic American.

peers+16%-43%-12%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -12% path vs comparable companies over six months, inside the middle-half range (+16% to -43%). A base rate, not a forecast.
  • Late SEC filingcondition set before this filing

    Across all companies, this kind of break has happened 4,811 times before. Those stocks trailed comparable companies by a median of 12% over the next six months, and 52% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Atlantic American filed an SEC 8-K on 2026-10-16: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Delisting notice or listing-rule failure.

    Atlantic American filed an SEC 8-K on 2026-08-26: Delisting notice or listing-rule failure. It is a dated development that tests the current thesis.

  3. Mixed
    Entered a material definitive agreement.

    Atlantic American filed an SEC 8-K on 2026-08-05: Entered a material definitive agreement. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Independent agents, brokers, or program partners move niche accounts to larger insurers with better ratings, broader products, or lower prices.
  • Medical-cost inflation or adverse morbidity in life and health products outpaces approved rate increases.
  • Reserve strengthening or claim payments require asset sales at unfavorable prices.
  • Further adverse reserve development reduces statutory or GAAP capital.

AAME news

Loading headlines…

Financial statements

AAME income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

AAME: quick answers

What is AAME's short interest?
As of October 30, 2026, 62,902 AAME shares were sold short, 0.31% of its shares outstanding, up 148.5% from the count before. At the stock's average daily volume that is 1.0 day to cover. FINRA publishes the count twice a month. AAME short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.